{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:07:40Z","timestamp":1788869260807,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tcm.2026.04.001","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T23:20:46Z","timestamp":1775690446000},"page":"422-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial commentary: Importance of the surgical myectomy option in the changing landscape of management for symptomatic obstructive hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"36","author":[{"given":"Barry J.","family":"Maron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2026.04.001_bib0001","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjcard.2022.06.007","article-title":"Ventricular septal myectomy for obstructive hypertrophic cardiomyopathy. (Spanning 60 years of practice): AJC Expert Panel","volume":"180","author":"Maron","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.04.001_bib0002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.amjcard.2022.02.035","article-title":"Sixty year evolution of surgical myectomy for symptomatic obstructive hypertrophic cardiomyopathy with insights from the historic NIH surgical experience to present","volume":"172","author":"Maron","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.04.001_bib0003","unstructured":"Maron B.J., Ommen S.R., Nishimura R.A., McKenna W.J., Rakowski H., Sherrid M.V., et al. Evolution and transformation of hypertrophic cardiomyopathy from a high risk to a treatable low mortality disease with contemporary clinical research strategies. JAHA, in press."},{"key":"10.1016\/j.tcm.2026.04.001_bib0004","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2026.04.001_bib0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomized, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2026.04.001_bib0006","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/CIRCULATIONAHA.124.072445","article-title":"Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: week 128 results from VALOR-HCM","volume":"151","author":"Desai","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.04.001_bib0007","unstructured":"Maron M.S., Quintana E., Dearani J., et al. Will surgical myectomy for symptomatic obstructive hypertrophic cardiomyopathy survive cardiac myosin inhibitors?: a call-to-action. Eur Heart J, submitted."},{"key":"10.1016\/j.tcm.2026.04.001_bib0008","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jamacardio.2025.1142","article-title":"Surgical treatment of hypertrophic cardiomyopathy in Ukraine during war","volume":"10","author":"Maron","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2026.04.001_bib0009","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2005.02.090","article-title":"Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy","volume":"46","author":"Ommen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.04.001_bib0010","doi-asserted-by":"crossref","unstructured":"Cui H., Lai Y.L., Schaff H.V. Septal reduction therapies for obstructive hypertrophic cardiomyopathy: current strategies and evolving innovations. Trends Cardiovasc Med, in press, 2026.","DOI":"10.1016\/j.tcm.2026.02.004"},{"key":"10.1016\/j.tcm.2026.04.001_bib0011","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacc.2023.05.052","article-title":"First in-human transapical beating heart septal myectomy in patients with hypertrophic obstructive cardiomyopathy","volume":"82","author":"Fang","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.04.001_bib0012","article-title":"The dilemma of \u201creal world\u201d (low volume) surgical myectomy for symptomatic obstructive hypertrophic cardiomyopathy","author":"Maron","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2026.04.001_bib0013","article-title":"Surgical myectomy for hypertrophic cardiomyopathy: procedural volume and outcome","author":"Heeringa","year":"2025","journal-title":"Eur Heart"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173826000551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173826000551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:18:21Z","timestamp":1788866301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173826000551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1050173826000551"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2026.04.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial commentary: Importance of the surgical myectomy option in the changing landscape of management for symptomatic obstructive hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2026.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}